BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3551437)

  • 1. Refractory anemia.
    Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1536-45. PubMed ID: 3551437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myelodysplastic syndromes: towards a functional classification.
    Mijović A; Mufti GJ
    Blood Rev; 1998 Jun; 12(2):73-83. PubMed ID: 9661795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myelodysplastic syndromes: current diagnosis and classification].
    Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
    Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
    [No Abstract]   [Full Text] [Related]  

  • 9. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S; Giallonardo P; Costa MP; Carducci P
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract]   [Full Text] [Related]  

  • 12. The JAK2 V617F mutation is rare in RARS but common in RARS-T.
    Ceesay MM; Lea NC; Ingram W; Westwood NB; Gäken J; Mohamedali A; Cervera J; Germing U; Gattermann N; Giagounidis A; Garcia-Casado Z; Sanz G; Mufti GJ
    Leukemia; 2006 Nov; 20(11):2060-1. PubMed ID: 16932338
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 14. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed myelodysplastic and myeloproliferative syndromes.
    Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
    Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes.
    Larripa I; Labal de Vinuesa M; Bengiò R; Slavutsky I
    Haematologica; 1987; 72(5):399-403. PubMed ID: 3121461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of IPSS for the patients with refractory anemia.
    Takahashi M; Takahashi H; Aizawa Y; Koike T
    Am J Hematol; 1998 Jul; 58(3):250-2. PubMed ID: 9662286
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncogene mutation and prognosis in the myelodysplastic syndromes.
    Padua RA; West RR
    Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transmission ultrastructure in the study of acquired refractory anemias].
    Woessner S; Lafuente R; Florensa L; Vilá RM; Sans-Sabrafen J
    Sangre (Barc); 1986; 31(1):40-56. PubMed ID: 3458311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.